Dose scheduling and pharmacokinetic (PK) study of trastuzumab in patients (pts) with HER2/neu overexpressing breast cancer?A. Felici, F. Cognetti, G. Ferretti et al.|Journal of Clinical Oncology|2007Cited by 3
Dose-escalating study of continuative low dose of oral vinorelbine in patients with advanced breast cancerAlessandra Felici, Paola Papaldo, Michelangelo Russillo et al.|Journal of Clinical Oncology|2009Cited by 0
Fulvestrant administered in two different schedules: Pharmacokinetics, biological markers, and activity.A. Felici, Paola Papaldo, Francesco Cognetti et al.|Journal of Clinical Oncology|2011Cited by 0